One obsolete drug and one Phase 2 drug in a company losing money.
yeah and up 6% today on the onxx news. If someone comes out with a better CF drug, 25 is more like it.
If you so sure, double up on your short position.
wow, how mis-informed can you get? you must have just emerged from a cave having been trapped there since may 2011.